The pSMAD2L-specific gene signature comprised 351 differentially expressed genes compared to wild-type cells, which encode for cancer-associated processes such as EMT, angiogenesis, and KRAS signalling (Fig. 4a). This evidence concerns the gene KRAS and cancer.